Skip to main content
. 2019 Jul 16;14:1569–1581. doi: 10.2147/COPD.S207621

Table 4.

Secondary outcome; times of hospitalization. Results are presented as means ±1 SD (range) for continuous variables and percentage for categorical variables. P-values are from Student’s t-test (P-value ≥0.05)

CHF (n=58) COPD (n=36) P-value
Times hospitalized 12 months prior inclusion, all causes, per subject 3.1±1.5 (2–10) 3.4±1.8 (2–9) n.s.
Times hospitalized during study period, all causes, per subject 0.8±1.3 (0–7) 1.2±1.5 (0–6) n.s.
Assessable months in the study
  • Prior inclusion

696 432
  • During the study

484 280
  • % of planned study months

70 65
After adjustment for assessable months
-Times hospitalized prior inclusion, all causes, per subject ***2.1±1.1 (1.4–7) **2.2±1.2 (1.3–5.8) n.s.

***<0.001 vs “during study period”; **<0.01 vs “during study period”.

Abbreviations: CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; N.s., not significant.